HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: R300007-MCP200v1 R300007-MCP200v2 2/6/369    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Celis, J. E. Articles by Rank, F. E. Search for Related Content PubMed PubMed Citation Articles by Celis, J. E. Articles by Rank, F. E. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 2:369-377, 2003.
© 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Review

Integrating Proteomic and Functional Genomic Technologies in Discovery-driven Translational Breast Cancer Research^*

Julio E. Celis^a,b,, Pavel Gromov^a,b, Irina Gromova^a,b, José M. A. Moreira^a,b, Teresa Cabezón^a,b, Noona Ambartsumian^a,c, Mariam Grigorian^a,c, Eugene Lukanidin^a,c, Per thor Straten^a,d, Per Guldberg^a,e, Jirina Bartkova^a,f, Jiri Bartek^a,f, Jiri Lukas^a,f, Claudia Lukas^a,f, Anne Lykkesfeldt^a,g, Marja Jäättelä^a,h, Peter Roepstorff^a,i, Lars Bolund^a,j, Torben Ørntoft^a,k, Nils Brünner^a,l, Jens Overgaard^a,m, Kerstin Sandelin^a,n, Mogens Blichert-Toft^a,o, Henning Mouridsen^a,p and Fritz E. Rank^a,q

From ^a The Danish Centre for Translational Breast Cancer Research, Strandboulevarden 49, DK-2100 Copenhagen, Denmark, ^b Department of Proteomics in Cancer, Institute of Cancer Biology, The Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark, ^c Department of Molecular Cancer Biology, Institute of Cancer Biology, The Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark, ^d Tumor Immunology Group, Institute of Cancer Biology, The Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark, ^e Laboratory of Cancer Genomics, Institute of Cancer Biology, The Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark, ^f Department of Cell Cycle and Cancer, Institute of Cancer Biology, The Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark, ^g Department of Tumor Endocrinology, Institute of Cancer Biology, The Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark, ^h Department of Apoptosis, Institute of Cancer Biology, The Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark, ⁱ Department of Biochemistry and Molecular Biology, Danish Biotechnology Instrument Centre, University of Southern Denmark, Campusvej 55, DK-5230 Odense, Denmark, ^j Department of Human Genetics, Aarhus University, Nordre Ringgade 1, DK-8000 Aarhus, Denmark, ^k Department of Clinical Biochemistry, Aarhus University, Nordre Ringgade 1, DK-8000 Aarhus, Denmark, ^l Department of Pharmacology and Pathobiology, Royal Veterinary and Agricultural University, Rolighedsvej 30, DK-1958 Frederiksberg, Denmark, ^m Department of Experimental Clinical Oncology, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus, Denmark, ⁿ Department of Breast and Endocrine Surgery, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark, ^o Danish Breast Cancer Cooperative Group, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark, ^p Department of Oncology, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark, and ^q Department of Pathology, The Centre of Diagnostic Investigations, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark

The application of state-of-the-art proteomics and functional genomics technologies to the study of cancer is rapidly shifting toward the analysis of clinically relevant samples derived from patients, as the ultimate aim of translational research is to bring basic discoveries closer to the bedside. Here we describe the essence of a long-term initiative undertaken by The Danish Centre for Translational Breast Cancer Research and currently underway for cancer biomarker discovery using fresh tissue biopsies and bio-fluids. The Centre is a virtual hub that brings together scientists working in various areas of basic cancer research such as cell cycle control, invasion and micro-environmental alterations, apoptosis, cell signaling, and immunology, with clinicians (oncologists, surgeons), pathologists, and epidemiologists, with the aim of understanding the molecular mechanisms underlying breast cancer progression and ultimately of improving patient survival and quality of life. The unifying concept behind our approach is the use of various experimental paradigms for the prospective analysis of clinically relevant samples obtained from the same patient, along with the systematic integration of the biological and clinical data.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. E. Celis, P. Gromov, J. M. A. Moreira, T. Cabezon, E. Friis, I. M. M. Vejborg, G. Proess, F. Rank, and I. Gromova Apocrine Cysts of the Breast: Biomarkers, Origin, Enlargement, and Relation with Cancer Phenotype Mol. Cell. Proteomics, March 1, 2006; 5(3): 462 - 483. [Abstract] [Full Text] [PDF]

				J. M. A. Moreira, G. Ohlsson, F. E. Rank, and J. E. Celis Down-regulation of the Tumor Suppressor Protein 14-3-3{sigma} Is a Sporadic Event in Cancer of the Breast Mol. Cell. Proteomics, April 1, 2005; 4(4): 555 - 569. [Abstract] [Full Text] [PDF]

				J. E. Celis, J. M. A. Moreira, T. Cabezon, P. Gromov, E. Friis, F. Rank, and I. Gromova Identification of Extracellular and Intracellular Signaling Components of the Mammary Adipose Tissue and Its Interstitial Fluid in High Risk Breast Cancer Patients: Toward Dissecting The Molecular Circuitry of Epithelial-Adipocyte Stromal Cell Interactions Mol. Cell. Proteomics, April 1, 2005; 4(4): 492 - 522. [Abstract] [Full Text] [PDF]

				J. E. Celis, P. Gromov, T. Cabezon, J. M. A. Moreira, N. Ambartsumian, K. Sandelin, F. Rank, and I. Gromova Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment: A Novel Resource for Biomarker and Therapeutic Target Discovery Mol. Cell. Proteomics, April 1, 2004; 3(4): 327 - 344. [Abstract] [Full Text] [PDF]

				H. T. Mouridsen and N. Brunner Clinical Infrastructures to Support Proteomic Studies of Tissue and Fluids in Breast Cancer Mol. Cell. Proteomics, April 1, 2004; 3(4): 302 - 310. [Abstract] [Full Text] [PDF]

				M. Huber, I. Bahr, J. R. Kratzschmar, A. Becker, E.-C. Muller, P. Donner, H.-D. Pohlenz, M. R. Schneider, and A. Sommer Comparison of Proteomic and Genomic Analyses of the Human Breast Cancer Cell Line T47D and the Antiestrogen-resistant Derivative T47D-r Mol. Cell. Proteomics, January 1, 2004; 3(1): 43 - 55. [Abstract] [Full Text] [PDF]